Medtronic

ADAPT-PD Global Study Designed to Demonstrate Safety & Efficacy of Automated Therapy Which Responds to Brain Signals in Parkinson’s Disease

DUBLIN, Jan. 4, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually

DUBLIN, Dec. 16, 2020 /PRNewswire/ — Medtronic plc (NYSE: MDT) announced that the U.S. Food and Drug Administration (FDA) has cleared

DUBLIN, Dec. 15, 2020 /PRNewswire/ — Medtronic plc (NYSE: MDT) today announced the release of outcomes in the first 100 patients

DUBLIN, Dec. 14, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT) announced today that Sean Salmon, Executive Vice President and President, Diabetes Operating

DUBLIN, Dec. 14, 2020 /PRNewswire/ — The board of directors of Medtronic plc (NYSE: MDT) on Friday, December 11, 2020, approved

DUBLIN, Dec. 8, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced the U.S. commercial launch of the Carpediem™ Cardio-Renal Pediatric

DUBLIN, Dec. 1, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually

DUBLIN, Nov. 30, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually

DUBLIN and MINNEAPOLIS, Nov. 30, 2020 /PRNewswire/ — With the pandemic surging across the globe and food insecurity on the rise,

- Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic - Q2 GAAP Diluted EPS of $0.36; Q2

DUBLIN, Nov. 17, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT) announced today that it will report financial results for its second quarter

DUBLIN, Nov. 16, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary

DUBLIN, Nov. 16, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has completed

DUBLIN, Nov. 13, 2020 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced that it has

DUBLIN, Nov. 12, 2020 /PRNewswire/ — Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the launch of

DUBLIN, Oct. 29, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S.

DUBLIN, Oct. 26, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food

DUBLIN, Oct. 20, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced statistically significant 12-month

Feasibility Study of Medtronic Drug-Coated Balloon Technology for Challenging Below-the-Knee Disease Shows Promise in Patients with Critical Limb Ischemia DUBLIN,

Company Raises Revenue Growth Outlook Highlights Deep and Broad Pipeline and Technology Platforms DUBLIN, Oct. 14, 2020 /PRNewswire/ — Medtronic plc

DUBLIN, Oct. 14, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, has been named one of America’s

Half Moon Medical’s Technology Now Ready for Evaluation in Early Feasibility Study DUBLIN, Oct. 14, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT),

Medtronic Also Begins Feasibility Study of Evolut TAVR System in Moderate and Asymptomatic Aortic Stenosis Patients DUBLIN, Oct. 14, 2020

Report Outlines Environmental, Social, and Governance (ESG) Topics Critical to the Company and Its Stakeholders DUBLIN, Oct. 13, 2020 /PRNewswire/